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There is an overwhelmingly increasing trend of analysis of naturally occurring ingredients in treatment of prostate
cancer. Substantial fraction of information has been added that highlights activity at various levels and steps of
deregulated cellular proliferation, metastasis and apoptosis. Among such ingredients, algae extracts and jasmonates
are documented to have anti-cancer activity in vitro and in vivo and induce growth inhibition in cancer cells, while
leaving the non-transformed cells intact. In this short review we outline systematically, how these ingredients
predispose prostate cancer cells to undergo apoptosis.Introduction
Scientists worldwide are making efforts to design tar-
geted therapies that can kill cancer cells without harm-
ing normal cells. Such therapies primarily rely on
understanding of how and by what mean cancer cells
differ from normal non-transformed cells. It is compre-
hensible that cancer cells do not resemble normal cells
in terms of morphology and behavior. Confluence of in-
formation suggests that bioactive components extracted
from algae, as well as methyl jasmonate (a natural com-
pound belongs to the jasmonates family of plant stress
hormones), seem to have anti-cancer activities through
multiple mechanisms of action, including inhibition of
cancer-cell growth and of invasion and metastasis, and
through the promotion of apoptosis of cancerous cells.
Considerable emerging evidence supports the inhibitory
actions of bioactive components of algae and methyl jas-
monate on prostate cancer. The purpose of this mini-
review is to bring to limelight the findings from recent
research regarding the potential effects and mechanisms
of action of bioactive components of algae and methyl
jasmonate on cancer. Finally, we highlight the research
efforts that need to be made to facilitate the optimal de-
velopment of algae derived bioactive ingredients.* Correspondence: Ammadahmad638@yahoo.com
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Cell death pathway is subdivided into two categories
namely extrinsic pathway and intrinsic pathway and
former is initiated by binding of the extracellular ligands,
TNF (tumour necrosis factor-) or FAS (apoptosis antigen-1)
ligand (FASL), to death receptors TNFR1 (TNF-receptor1)
and FAS. The resulting heteromeric complex activates
procaspase 8, that mediates apoptosis through caspase 3
or alternatively another pathway intrinsic pathway is
opted that initiates via cleavage of BID to tBID (trun-
cated BID). FAS-mediated death occurs through a
FADD-mediated activation of procaspase 8. Membrane
permeabilization is an important step in intrinsic path-
way and is mediated by BH3-only proteins, which se-
quester and restore the activity of BAX. It is notable
that BAX is switched off by BCL2 thus inhibiting
mitochondrial BAX translocation and the release of
cytochrome c (Cyto c), SMAC/DIABLO, AIF and
HTRA2/OMI. However activation of BAX facilitates
the release of proteins from mitochondrion and cyto-
chrome c interacts with APAF1 to recruit and activate cas-
pase 9, forming the apoptosome, which activates the
downstream executioner caspases 3 and 7. There is a push
and pull between pro-apoptotic and anti-apoptotic proteins
as SMAC/DIABLO sequesters and inhibits IAP proteins.
Cell uses its hidden modulators to counteract antiapoptotic
proteins (Farooqi et al., [1]; Farooqi et al., [2]).l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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death receptors are signaling members of the tumour-
necrosis factor receptor (TNFR) superfamily and decoy
receptors, by contrast, are a non-signalling subset of the
TNFR superfamily that abrogate death receptor
mediated signaling cascade. Although there are some
cells type specific studies that demonstrate potential of
algal extracts in re-sensitizing resistant cancer cells to
apoptosis via activation of death receptors (or block
decoy receptors). Siphonaxanthin, a marine carotenoid
from green algae has recently been demonstrated to de-
crease expression of Bcl-2 and remarkably enhanced ac-
tivation of caspase-3 alongwith up-regulated expression
of GADD45α and DR5 in human leukemia (HL-60) cells
(Ganesan et al., [3]). It is also encouraging to note that
there was a decline in levels of the X-linked inhibitor of
apoptosis protein and survivin in the fucoidan-treated
cells. Another study provided a multistep regulation of
cell death pathway via fucoidan and it was shown that
there was enhanced mitochondrial membrane perme-
ability, as well as the cytochrome c and Smac/Diablo re-
lease from the mitochondria. Bak and truncated Bid
proteins were raised in fucoidan treated cells, but a de-
cline was noted in the levels of Mcl-1. Additionally,
fucoidan increased the levels of the TRAIL, Fas and
death receptor 5 proteins Kim et al., [4].
In the following segment we focus on how research
with emphasis on algal extracts and methyl jasmonates
roleplay in induction of apoptosis is sequentially and
progressively maturing. We have developed a roadmap
of research from key discoveries in fundamental biology
to potential therapeutic applications.Algae
Cellular and molecular studies have shown algae derived
ingredients to be potent naturally occurring anticancer
compounds and have been suggested to prevent
carcinogenesis.
Fucoxanthin is a marine carotenoid found in brown
algae and is documented to display remarkable antican-
cer activity. Fucoxanthin suppressed the growth of
LNCap prostate cancer cells in a concentration-
dependent manner along with the induction of
GADD45A expression and G(1) cell cycle arrest, but not
apoptosis. Fucoxanthin activated c-Jun N-terminal kin-
ase (SAPK/JNK), whereas the targeted inhibition of
SAPK/JNK repressed the induction of G(1) arrest and
GADD45A expression by fucoxanthin (Satomi et al.,
[5]). Another study had demonstrated notable efficacy of
fucoxanthin metabolites (dietary fucoxanthin is hydro-
lyzed into fucoxanthinol) on the proliferation of PC-3
human prostate cancer cells (Asai et al., [6]; Ishikawa
et al., [7]). Fucoxanthin was effective against variousprostate cancer cell lines like PC-3, DU 145and LNCaP
(Kotake-Nara et al., [8]).
Benzochromenone is a pigment obtained from an ac-
tive extract of the marine crinoids Comantheria rotula
using Bioassay-guided fractionation and significantly
inhibited hypoxia inducing factor (HIF) activity, however
vascular endothelial growth factor (VEGF), the target
gene of HIF was not considerably repressed. Nonetheless
these crinoids pigments differentially suppressed the
growth of certain tumor cell lines Dai et al., [9]. Sodwa-
none a triterpenoid from a South African species of the
marine sponge was also tested to be effective in inhibit-
ing HIF-1 activation in PC-3 prostate tumor cells (Dai
et al., [10]).
14-keto-stypodiol diacetate is a drug extracted from
the algae Stypopodium flabelliforme and was indicated to
disrupt microtubular organization and also inhibited cel-
lular proliferation in DU-145 human prostatic cells
(Depix et al., [11]). Glycoprotein of Capsosiphon fulves-
cens, a green sea algae induces apoptosis in human gas-
tric cancer (AGS) cells Kim et al., [12].Fucose-containing
sulfated polysaccharides (FCSPs) extracted from brown
macro-algae are documented to induce apoptosis Ale
et al., [13]. Studies have been performed that reveal the
fact that Quinones and halogenated monoterpenes of
algal origin are effective in inducing apoptosis in breast
cancer cells in vitro de la Mare et al., [14].
Recently, efficacy of meroditerpenoids isolated from
the brown alga Stypopodium flabelliforme were tested
and it was demonstrated that these meroditerpenoids
showed considerable activity against different cancer cell
lines Pereira et al., [15].Yessotoxins obtained from red-
tide algae, Protoceratium reticulatum are also effective
in terms of induction of apoptosis Pang et al., [16]. Ela-
tol, a compound (sesquiterpene) isolated from algae
Laurencia microcladia displayed a remarkable reduction
in tumour growth in C57BL6 mice (Campos et al., [17]).
Bis(2,3-dibromo-4,5-dihydroxybenzyl) ether (BDDE) is a
marine bromophenol compound derived from marine
algae has recently been tested for apoptotic activity in
K562 cells and is suggested to have potent activity (Liu
et al., [18]). Mineral-rich extract derived from the red
marine algae, Lithothamnion calcareum is effective in
suppressing growth and inducing differentiation of colon
carcinoma cells Aslam et al., [19].
Sargassum siliquastrum derived sargachromanol E
(SE) is a chromene and has growth inhibitory effects on
HL-60 cells in a concentration-dependent manner. The
compound was also noted to induce apoptosis via cas-
pase 3 activation (Heo et al., [20]). Polysaccharides
extracted from the brown alga, Sargassum latifolium
have considerable anticancer activity against leukemia
Gamal-Eldeen et al., [21]. Fucoxanthin has also been
tested for re-sensitizing the cells to drugs and findings
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The sensitization was restored by inhibition of drug re-
sistance associated genes (rifampin-induced CYP3A4
and MDR1) expression in HepG2 hepatoma cells Liu
et al., [22].
Triprenylated toluquinones and toluhydroquinones
isolated from the Arminacean nudibranch Leminda
millecra are also reported to induce ROS mediated
apoptosis in esophageal cancer cells Whibley et al., [23].
Contrary to previously described algae derived compo-
nents which induce apoptosis, diphlorethohydroxycar-
malol (DPHC), isolated from the brown algae Ishige
okamurae, reduces the ROS levels and consequently
reduced apoptosis in cells exposed to radiations (Ahn
et al., [24]).
Radioprotective role of algal extracts
In accordance with same concept, diphlorethohydroxy-
carmalol (DPHC), isolated from the brown algae Ishige
okamurae, notably reduced the level of radiation-
induced intracellular ROS and protected cells from
undergoing cell death in cultured Chinese hamster lung
fibroblast (V79-4) cells Ahn et al., [24].
Jasmonates
Continuous research has offered better understanding of
the fundamental processes involved in biosynthesis and
the regulation of Jasmonic acid (JA) and its methyl ester,
methyl jasmonate (MeJA), which are naturally occurring
growth regulators found in higher plants. JA was first
isolated from culture filtrates of the fungus Lasiodiplodia
theobromae Griff. & Maubl., and MeJA was described as
a component of the essential oils of Jasminum grandi-
forum L. and Rosmanus offincinalis L (Hu et al., [25])
and recently, these agents have received renewed consid-
eration owing to reported anticancer properties. Accu-
mulated evidence from experimental studies suggested
that the structures of JA and MeJA were similar to mam-
malian eicosanoids, which were potent modulators of
smooth muscle contraction and inflammatory responses.
Various studies verified the fact that both eicosanoids and
JA were derived from lipids in lipoxygenase-dependent
pathways (Schaller and Stintzi, [26]).
Keeping in view the fact that Jasmonates have started
to receive attention, several of the approaches based on
targeting core components of the cell death machinery
for cancer therapy are reviewed here.
It is worth mentioning that methyl jasmonate (MJ) and
cis-jasmone (CJ) are documented to induce inhibition of
growth in hormone independent prostate cancer cell lines,
PC-3 and DU-145 (Yeruva et al., [27]). One study has
indicated that overexpressed inhibitors of apoptosis (IAP)
proteins in cancer cells often dampen the pro-apoptotic
activity of methyl jasmonates. However introduction ofIAP antagonists like SmacN7, potentiates MJ mediated
apoptosis (Jiang et al., [28]).
Methyl jasmonate mediated apoptosis in A549 human
lung adenocarcinoma cells was induced through activa-
tion of Bax and caspase-3 via reactive oxygen species
production (ROS) (Kim et al., [29]). It is also attention-
grabbing to note that methyl jasmonate suppresses the
radiation-induced Bcl-2 expression and enhances the ra-
diation sensitivity of prostate cancer cells (Ezekwudo
et al., [30]).
Emerging findings provide ample evidence that pros-
tate cancer cells constitutively generate 5-lipoxygenase
(5-LOX) metabolites from arachidonic acid, and targeted
inhibition of 5-LOX inhibits generation of 5-LOX meta-
bolites and promotes cell death. MJ notably repressed
uncontrolled proliferation of prostate cancer cells and
showed specific interaction with 5-LOX enzyme pathway
(Ezekwudo et al., [31]).
Jasmonates and chemotherapeutic drugs
MJ displayed remarkably enhanced efficacy in combin-
ation with chemotherapeutic drugs in inducing death of
several types of carcinoma cells (Heyfets et al., [32]).
Various lines of evidence indicate that MJ can be added
also to conventional X-ray and cisplatin therapeutic
approaches to substantially improve their cytotoxic ef-
fect whereas lowering the effective dose (Milrot et al.,
[33]). Recently, a research group reported a new jasmo-
nic acid stereoisomeric derivative that had remarkable
potential to induce apoptosis in prostate cancer cells. It
is worth explaining that ROS generation is a major
mechanism that is opted to induce apoptosis (Russo
et al., [34]). It has lately been explored that Perillyl alco-
hol (POH) and MJ treatment activated TNFR1 and re-
sponse was increased by the addition of cisplatin
(Yeruva et al., 2010[35]).
Jasmonates and TRAIL join hands
Tumour necrosis factor-related apoptosis-inducing lig-
and (TRAIL) has emerged as a potent anticancer agent
in laboratory-based studies and preclinical trials. In this
forth coming section we discuss, the experimental evi-
dence that supports a role for jasmonates in sensitizing
cancer cells to TRAIL mediated apoptosis. Adding to-
gether different pieces of information indicate that al-
though TRAIL is able to induce apoptosis in prostate
cancer cell, yet overexpression of antiapoptotic proteins
and inhibition of pro-apoptotic proteins results in dam-
pening the TRAIL mediated apoptosis. Another import-
ant feature is that the receptors (death receptors) of
TRAIL are outnumbered by decoy receptors that further
confound TRAIL mediated therapy (Figure 1).
MJ is documented to be involved in suppressing the
negative regulators of TRAIL mediated apoptosis. In line
Figure 1 Showing TRAIL mediated apoptosis. There is an overexpression of antiapoptotic proteins that impairs the cell death. Jasmonates
induce apoptosis via multistep activity.
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negatively regulated TRAIL mediated apoptosis. Aston-
ishingly, MJ-induced TRAIL sensitization was observed
and overexpression of survivin prevented MJ-induced
TRAIL cytotoxicity (Raviv et al., [36]). On a similar note,
J7, a novel MJ analogue enhances TRAIL-induced apop-
tosis. The apoptosis was induced via Bid cleavage, down-
regulation of XIAP, cIAP-1 and Bcl-xL and activation of
caspases (Park et al., [37]) (Figure 1).
It has been shown extensively previously that mixtures
of interacting compounds underscore vital combination
therapies that concurrently hit effectively multiple
pharmacological targets and provide effectiveness be-
yond the reach of single compound–based drugs. In ac-
cordance with the multiple properties of algae derived
components and methyl jasmonates, development of in-
novative scientific methods for discovery, validation,
characterization and standardization of these multicom-
ponent therapeutics is essential to their acceptance into
mainstream medicine. Therefore it is indispensable that
attention needs to be focused on intracellular-signalling
cascades as common molecular targets for these agents.Conclusion
With incredible progress in exploring the efficacy of
herbal extracts as potent anticancer agents various lim-
itations do exist. It is important to have characterization
of bioactive components as various components having
opposite effects on the cells impair the efficacy when
combined with the agents believed to induce apoptosis.
In line with this approach, a recent study indicates that
aqueous extracts of Gracilaria tenuistipitata are docu-
mented to rescue cells from undergoing apoptosis (Yang
et al., [38]). Contrary to this metahnolic/ethanolic
extracts were proved to be potent anticancer agents.
Ca9-22 oral cancer cell line was tested for efficacy of
Methanolic extracts of Gracilaria tenuistipitata and
results indicated that the extracts induced apoptosis in
cancer cells via enhanced ROS production and DNA
damage (Yeh et al., [39]). Interestingly, Ethanolic
Extracts of Gracilaria tenuistipitata were also found to
be effective in concentration dependent manner in oral
cancer cells (Yeh et al., [40]).
Accumulating data offers new insights in the study of
alternative therapeutic strategies in the treatment of
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given to the differences in the cellular biology of sensi-
tive tumours that could explain the cytotoxic effect of
algae derived ingredients and the increase in the cyto-
toxic response caused by these biomolecules, in particu-
lar cancer types. Our laboratory is focusing and studying
biological activities of various extracts derived from
local strains of algae (Ghazala et al., [41]; Ghazala et al.,
[42]; Ghazala et al., [42]; Ghazala and Shameel, [43];
Ghazala et al., [44]; Ghazala et al., [45]; Ghazala et al.,
[46]; Ghazala et al.,[47]). Additionally anticancer poten-
tial of these extracts is currently being tested to identify
agents which could improve the efficacy of mechanism-
based and targeted therapeutic strategies against cancer.
It is appealing to note that prevention of prostate can-
cer could occur in a multipronged manner. These
approaches include counteracting uncontrolled cellular
proliferation, restoration of cell death pathway, and re-
pression of the factors that underlie genesis of genomic
rearrangements in prostate cancer cells.
No published research has addressed the effects of
algae derived components or methyl jasmonates on
intraprostatic sex-steroid levels. Additionally, how these
ingredients influence the expression and activity of the
androgen receptor (a key mediator of the effects of
androgens) is also unknown and direction of future clin-
ical trials lies in clarifying the effects of these agents and
exploring the biological mechanisms responsible for the
prevention of prostate cancer. Furthermore, there are
various signaling mechanisms that work synchronously
and facilitate escape of cells from apoptosis Farooqi
et al., [48]. In addition there are miRNA’s which are cate-
gorized into oncomirs and tumor suppressors and are
documented to be involved in regulation of apoptosis
are also attractive targets. A recent study indicated that
pomegranate juice stimulated the expression of tumor
suppressor miRNA’s and downregulated oncomirs in
prostate cancer Wang et al., [49]. Likely, mechanisms
that underpin initiation and progression of prostate can-
cer so far proposed include AR mutations, allowing
receptors to be activated by new ligands. AR gene over-
expression causing AR hypersensitivity to declining con-
centrations of androgen and cross-stimulation of AR
signaling by other growth factors and how AR transmi-
gration into nucleus to modulate transcriptional network
are some of the prominent features that need a detailed
investigation with reference to methyl jasmonates and
algae derived components.
It is worthwhile that latest biology and high-tech gen-
omics research are helping us in devising treatments that
target stratified proteome of cancer cell. Keeping in view
cellular plasticity and cancer heterogeneity, therapeutic
interventions are less effective with threatening off target
effects. Moreover, many anticancer drugs work by killingall the dividing cells — not just the cancerous ones but
healthy cells in addition.
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